Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Increased brain atrophy over 3 years in stroke survivors is linked to early post-stroke cognitive impairment

View ORCID ProfileAmy Brodtmann, Emilio Werden, Mohamed Salah Khlif, Laura J. Bird, View ORCID ProfileNatalia Egorova, View ORCID ProfileMichele Veldsman, Heath Pardoe, Graeme Jackson, Jennifer Bradshaw, David Darby, Toby Cumming, Leonid Churilov, Geoffrey Donnan
doi: https://doi.org/10.1101/2021.08.03.21261461
Amy Brodtmann
1The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, Australia
2Melbourne Dementia Research Centre, Florey Institute and University of Melbourne
7Melbourne Medical School, University of Melbourne
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Amy Brodtmann
  • For correspondence: agbrod@unimelb.edu.au
Emilio Werden
1The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohamed Salah Khlif
1The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laura J. Bird
1The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Natalia Egorova
1The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, Australia
2Melbourne Dementia Research Centre, Florey Institute and University of Melbourne
3Melbourne School of Psychological Sciences, University of Melbourne
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Natalia Egorova
Michele Veldsman
1The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, Australia
4Department of Experimental Psychology, University of Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michele Veldsman
Heath Pardoe
5Department of Neurology, NYU Grossman School of Medicine, New York, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Graeme Jackson
1The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, Australia
7Melbourne Medical School, University of Melbourne
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer Bradshaw
6Department of Clinical Neuropsychology, Austin Health, Heidelberg, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Darby
1The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, Australia
2Melbourne Dementia Research Centre, Florey Institute and University of Melbourne
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Toby Cumming
1The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leonid Churilov
7Melbourne Medical School, University of Melbourne
1The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Geoffrey Donnan
1The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, Australia
7Melbourne Medical School, University of Melbourne
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Background Stroke survivors are at high risk of dementia, associated with increasing age and vascular burden and with pre-existing cognitive impairment, older age. Brain atrophy patterns are recognised as signatures of neurodegenerative conditions, but the natural history of brain atrophy after stroke remains poorly described. We sought to determine whether stroke survivors who were cognitively normal at time of stroke had greater total brain (TBV) and hippocampal volume (HV) loss over 3 years than controls. We examined whether stroke survivors who were cognitively impaired (CI) at 3 months following their stroke had greater brain volume loss than cognitively normal (CN) stroke participants.

Methods Cognition And Neocortical Volume After Stroke (CANVAS) study is a multi-centre cohort study of first-ever or recurrent adult ischaemic stroke participants compared to age- and sex-matched community controls. Participants were followed with MRI and cognitive assessments over 3 years and were free of a history of cognitive impairment or decline at inclusion. Our primary outcome measure was TBV change between 3 months and 3 years; secondary outcomes were TBV and HV change comparing CI and CN participants. We investigated associations between group status and brain volume change using a baseline-volume adjusted linear regression model with robust standard error.

Results Ninety-three stroke (26 women, 66.7±12 years) and 39 control participants (15 women, 68.7±7 years) were available at 3 years. TBV loss in stroke patients was greater than controls: stroke mean (M)=20.3cm3±SD14.8cm3; controls M=14.2cm3±SD13.2cm3; (adjusted mean difference 7.88 95%CI [2.84,12.91] p-value=0.002). TBV decline was greater in those stroke participants who were cognitively impaired (M=30.7cm3; SD=14.2cm3) at 3 months (M=19.6cm3; SD=13.8cm3); (adjusted mean difference 10.42; 95%CI [3.04,17.80], p-value=0.006). No statistically significant differences in HV change were observed.

Conclusions Ischaemic stroke survivors exhibit greater neurodegeneration compared to stroke-free controls. Brain atrophy is greater in stroke participants who were cognitively impaired people early after their stroke. Early cognitive impairment may predict greater subsequent atrophy, reflecting the combined impacts of stroke and vascular brain burden. Atrophy rates could serve as a useful biomarker for trials testing interventions to reduce post-stroke cognitive impairment.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

http://www.clinicaltrials.gov NCT02205424

Funding Statement

This work was supported by: NHMRC GNT1020526, GNT1045617(AB), GNT1094974; Brain Foundation; Wicking Trust; Collie Trust; Sidney and Fiona Myer Family Foundation; Australian Research Council DE180100893(NE) and Heart Foundation Future Leader Fellowship 100784(AB).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Austin Health HREC H2012-04650 was the central authority - protocol also approved at Eastern Health HREC (Box Hill Hospital) and Melbourne Health HREC (RMH)

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The data collected for this study is available on request to the authors. The study protocol was published in 2014 and is freely available. Data requests should be sent to the corresponding author and will be evaluated and approved after consultation with CANVAS chief investigators. One-year data (not part of this study) have already been shared with the ENIGMA Stroke Recovery consortium http://enigma.ini.usc.edu/ongoing/enigma-stroke-recovery/. We have committed to sharing CANVAS data with the STROKOG consortium. CANVAS also has a 5-year follow-up timepoint (not presented here). It is a requirement of the funding for this timepoint that it will be made publicly available once complete (expected completion and compilation late 2021 due to pandemic delays). This will include de-identified participant data including MRI data. Data will be shared at reasonable request following review by the CANVAS data steering committee.

  • Non-standard Abbreviations and Acronyms

    CANVAS
    Cognition And Neocortical Volume After Stroke
    CCI
    Charlson Comorbidity Index
    CDR
    Clinical Dementia Rating
    CI
    cognitively impaired
    CN
    cognitively normal
    HV
    hippocampal volume
    IQCODE
    Informant Questionnaire on Cognitive Decline in the Elderly Short Form
    NART
    National Adult Reading Test
    TBV
    total brain volume
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted August 05, 2021.
    Download PDF

    Supplementary Material

    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Increased brain atrophy over 3 years in stroke survivors is linked to early post-stroke cognitive impairment
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Increased brain atrophy over 3 years in stroke survivors is linked to early post-stroke cognitive impairment
    Amy Brodtmann, Emilio Werden, Mohamed Salah Khlif, Laura J. Bird, Natalia Egorova, Michele Veldsman, Heath Pardoe, Graeme Jackson, Jennifer Bradshaw, David Darby, Toby Cumming, Leonid Churilov, Geoffrey Donnan
    medRxiv 2021.08.03.21261461; doi: https://doi.org/10.1101/2021.08.03.21261461
    Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
    Citation Tools
    Increased brain atrophy over 3 years in stroke survivors is linked to early post-stroke cognitive impairment
    Amy Brodtmann, Emilio Werden, Mohamed Salah Khlif, Laura J. Bird, Natalia Egorova, Michele Veldsman, Heath Pardoe, Graeme Jackson, Jennifer Bradshaw, David Darby, Toby Cumming, Leonid Churilov, Geoffrey Donnan
    medRxiv 2021.08.03.21261461; doi: https://doi.org/10.1101/2021.08.03.21261461

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Neurology
    Subject Areas
    All Articles
    • Addiction Medicine (161)
    • Allergy and Immunology (416)
    • Anesthesia (91)
    • Cardiovascular Medicine (860)
    • Dentistry and Oral Medicine (159)
    • Dermatology (97)
    • Emergency Medicine (250)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (394)
    • Epidemiology (8562)
    • Forensic Medicine (4)
    • Gastroenterology (384)
    • Genetic and Genomic Medicine (1753)
    • Geriatric Medicine (167)
    • Health Economics (373)
    • Health Informatics (1244)
    • Health Policy (621)
    • Health Systems and Quality Improvement (468)
    • Hematology (196)
    • HIV/AIDS (374)
    • Infectious Diseases (except HIV/AIDS) (10303)
    • Intensive Care and Critical Care Medicine (553)
    • Medical Education (192)
    • Medical Ethics (51)
    • Nephrology (212)
    • Neurology (1678)
    • Nursing (97)
    • Nutrition (251)
    • Obstetrics and Gynecology (326)
    • Occupational and Environmental Health (451)
    • Oncology (929)
    • Ophthalmology (263)
    • Orthopedics (102)
    • Otolaryngology (172)
    • Pain Medicine (114)
    • Palliative Medicine (40)
    • Pathology (253)
    • Pediatrics (536)
    • Pharmacology and Therapeutics (253)
    • Primary Care Research (208)
    • Psychiatry and Clinical Psychology (1770)
    • Public and Global Health (3841)
    • Radiology and Imaging (624)
    • Rehabilitation Medicine and Physical Therapy (320)
    • Respiratory Medicine (520)
    • Rheumatology (208)
    • Sexual and Reproductive Health (168)
    • Sports Medicine (158)
    • Surgery (190)
    • Toxicology (36)
    • Transplantation (101)
    • Urology (76)